The results from the two clinical cases prompted us to analyze additional retrospective high-dimensional flow cytometry data in an exploratory cohort of 32 NSCLC patients under treatment with PD-L1/PD-1 blockade therapies. Here, CD274 is linked to non-small cell lung carcinoma.